Citation: Scl. Koh et al., THE INFLUENCE OF LABOR AND PLACENTAL SEPARATION ON HEMOSTASIS IN TERMPREGNANCY, Clinical and applied thrombosis/hemostasis, 4(4), 1998, pp. 262-267
Citation: Scl. Koh et al., THE EFFECTS OF LONG-TERM HORMONE-REPLACEMENT THERAPY ON COAGULATION, FIBRINOLYSIS AND INHIBITORS IN POSTMENOPAUSAL WOMEN, International journal of gynaecology and obstetrics, 62(3), 1998, pp. 279-285
Citation: P. Kuperan et al., COAGULATION AND FIBRINOLYTIC MARKERS IN SYMPTOMATIC AND ASYMPTOMATIC PATIENTS WITH THROMBOPHILIA, Thrombosis and haemostasis, 1997, pp. 781-781
Authors:
KOH SCL
ARULKUMARAN S
ANANDAKUMAR C
CHUA SE
YUEN WK
NG BL
RATNAM SS
Citation: Scl. Koh et al., THE INFLUENCE OF LABOR AND PLACENTAL SEPARATION ON FIBRINOLYSIS, INHIBITOR AND COAGULATION ACTIVATION, Thrombosis and haemostasis, 1997, pp. 2985-2985
Citation: Scl. Koh et al., FIBRINOLYSIS, INHIBITORS AND COAGULATION ACTIVATION IN SUBJECTS ON LONG-TERM LOW-DOSE ORAL-CONTRACEPTIVE CONTAINING GESTODENE, Thrombosis and haemostasis, 1997, pp. 3010-3010
Authors:
TOMER Y
VIEGAS OAC
SWISSA M
KOH SCL
SHOENFELD Y
Citation: Y. Tomer et al., LEVELS OF LUPUS AUTOANTIBODIES IN PREGNANT SLE PATIENTS - CORRELATIONS WITH DISEASE-ACTIVITY AND PREGNANCY OUTCOME, Clinical and experimental rheumatology, 14(3), 1996, pp. 275-280
Citation: Oac. Viegas et al., THE EFFECTS OF REFORMULATED 2-ROD NORPLANT(R) IMPLANT ON HEMOSTASIS AFTER 3 YEARS, Contraception, 54(4), 1996, pp. 219-228
Authors:
KOH SCL
PUA HL
TAY DHB
CHUA SE
YUEN WK
NG BL
RATNAM SS
Citation: Scl. Koh et al., THE EFFECTS OF GYNECOLOGICAL SURGERY ON FIBRINOLYSIS, FIBRINOLYTIC INHIBITOR AND THE HEMOSTATIC STATUS AS ASSESSED BY THROMBOELASTOGRAPHY, Thrombosis and haemostasis, 73(6), 1995, pp. 1138-1138
Authors:
KOH SCL
ANANDAKUMAR C
ARULKUMARAN S
CHUA SE
YUEN WK
NG BL
RATNAM SS
Citation: Scl. Koh et al., AMNIOTIC-FLUID PLASMINOGEN ACTIVATORS AND INHIBITORS AND TAT-COMPLEX LEVELS DURING 2ND TRIMESTER PREGNANCY AND LABOR, Fibrinolysis, 9(2), 1995, pp. 121-126
Citation: Scl. Koh et al., THE EFFECTS OF GYNECOLOGICAL SURGERY ON COAGULATION ACTIVATION, FIBRINOLYSIS AND FIBRINOLYTIC INHIBITOR IN PATIENTS WITH AND WITHOUT KETOROLAC INFUSION, Thrombosis research, 79(5-6), 1995, pp. 501-514
Citation: Scl. Koh et al., PLASMINOGEN ACTIVATORS, PLASMINOGEN-ACTIVATOR INHIBITORS AND MARKERS OF INTRAVASCULAR COAGULATION IN PREECLAMPSIA, Gynecologic and obstetric investigation, 35(4), 1993, pp. 214-221
Citation: Scl. Koh et al., U-PA AND PAI-2 LEVELS IN PREECLAMPSIA AND THEIR RELATION TO OUTCOME OF PREGNANCY, Thrombosis and haemostasis, 69(6), 1993, pp. 716-716